Q1 2026 CorMedix Inc Earnings Call Transcript

May 14, 2026 / 12:30 PM GMT

Release Date Price: €6.76 (+6.69%)

Transcript 10-Q8-K

Key Points

Positve

Cormedix Inc (CRMD) reported first-quarter net revenue of $127.4 million, significantly above street consensus.
The company increased its full-year financial guidance for net revenue to a range of $325 million to $345 million.
Adjusted EBITDA guidance was raised to a new range of $115 million to $135 million, reflecting strong first-quarter execution.
The RESPECT study met its primary endpoint, showing non-inferiority of ROSEO compared to the standard antifungal regimen.
Cormedix Inc (CRMD) ended the quarter with $178.1 million in cash and cash equivalents, indicating a strong financial position.

Negative

The expiration of the initial TDAPA reimbursement is expected to cause variability in DefenCath sales in the second half of 2026.
The Phase III TPN study is experiencing delays, with completion now trending into 2028 due to lower-than-expected enrollment.
Operating expenses increased to $41.5 million in the quarter, driven by higher personnel-related costs and development activity.
The company anticipates incurring incremental spend in the back half of the year for commercial readiness of ROSEO.
The tax rate was noted to be high, at about 28%, impacting the company's financials.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CRMD.OQ - CorMedix Inc
Q1 2026 CorMedix Inc Earnings Call
May 14, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Update conference call. Today's question-and-answer session at the end of today's presentation and instructions on how to ask a question will be given at that time.

At this time, I would like to turn the conference call over to Dan Ferry from Life Science Advisors. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning, and welcome to the CoreMatix first quarter 2026 earnings and corporate update conference call.

Leading the call today is Joe Tedisko, Chairman and Chief Executive Officer of CoreMatix.

And he is joined by Liz Hurlbert, EVP and

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.